Fig. 3
From: Impact of weight trajectory after bariatric surgery on co-morbidity evolution and burden
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12913-020-5042-9/MediaObjects/12913_2020_5042_Fig3_HTML.png)
Total 10-year co-morbidity treatment and costs by post-surgical weight loss trajectory group. Results shown indicate the total 10-year burden in patient-years of treatment of co-morbidities and corresponding costs (millions, 2018 Canadian dollars) associated with a 100-patient cohort’s following each of the weight loss trajectories (see Fig. 2) after Roux-en-Y gastric bypass surgery. Bars indicate median values and error ranges are 95% CrIs from 10,000 iterations in sensitivity analyses. CAD, Canadian dollars; DLP, dyslipidaemia; HTN, hypertension; bypass; T2D, type 2 diabetes mellitus